- Home
- FTI vs MEDP Comparison
FTI vs MEDP Comparison
Compare FTI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- MEDP
- Stock Information
- Founded
- FTI 1884
- MEDP 1992
- Country
- FTI United States
- MEDP United States
- Employees
- FTI N/A
- MEDP N/A
- Industry
- FTI Metal Fabrications
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FTI Industrials
- MEDP Health Care
- Exchange
- FTI Nasdaq
- MEDP Nasdaq
- Market Cap
- FTI 12.7B
- MEDP 10.5B
- IPO Year
- FTI N/A
- MEDP 2016
- Fundamental
- Price
- FTI $32.58
- MEDP $337.35
- Analyst Decision
- FTI Strong Buy
- MEDP Buy
- Analyst Count
- FTI 13
- MEDP 10
- Target Price
- FTI $35.42
- MEDP $389.00
- AVG Volume (30 Days)
- FTI 3.5M
- MEDP 235.7K
- Earning Date
- FTI 02-27-2025
- MEDP 02-10-2025
- Dividend Yield
- FTI 0.61%
- MEDP N/A
- EPS Growth
- FTI N/A
- MEDP 33.84
- EPS
- FTI 1.43
- MEDP 11.42
- Revenue
- FTI $8,796,600,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- FTI $16.28
- MEDP $13.95
- Revenue Next Year
- FTI $9.78
- MEDP $5.49
- P/E Ratio
- FTI $22.72
- MEDP $29.53
- Revenue Growth
- FTI 17.82
- MEDP 16.24
- 52 Week Low
- FTI $18.54
- MEDP $286.76
- 52 Week High
- FTI $33.45
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- FTI 67.09
- MEDP 47.28
- Support Level
- FTI $32.04
- MEDP $327.00
- Resistance Level
- FTI $32.81
- MEDP $359.63
- Average True Range (ATR)
- FTI 0.85
- MEDP 9.20
- MACD
- FTI 0.20
- MEDP -0.72
- Stochastic Oscillator
- FTI 82.03
- MEDP 31.73
About FTI TechnipFMC plc
TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.